ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 145 filers reported holding ARGENX SE in Q1 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $51,597 | +6.1% | 119,983 | -2.8% | 0.07% | +6.2% |
| Q1 2024 | $48,623 | -12.6% | 123,497 | -15.5% | 0.06% | -16.9% |
| Q4 2023 | $55,607 | -11.0% | 146,168 | +15.0% | 0.08% | -14.4% |
| Q3 2023 | $62,504 | +18.9% | 127,136 | -5.7% | 0.09% | +34.3% |
| Q2 2023 | $52,547 | +5.9% | 134,830 | +1.2% | 0.07% | +1.5% |
| Q1 2023 | $49,624 | +11.1% | 133,190 | +12.9% | 0.07% | +8.2% |
| Q4 2022 | $44,681 | -99.9% | 117,944 | -1.9% | 0.06% | 0.0% |
| Q3 2022 | $42,462,000 | -10.3% | 120,271 | -3.7% | 0.06% | -1.6% |
| Q2 2022 | $47,342,000 | +22.5% | 124,953 | +1.9% | 0.06% | +51.2% |
| Q1 2022 | $38,653,000 | +6.5% | 122,587 | +18.3% | 0.04% | +13.9% |
| Q4 2021 | $36,300,000 | -3.0% | 103,659 | -16.4% | 0.04% | -10.0% |
| Q3 2021 | $37,441,000 | -2.0% | 123,977 | -2.3% | 0.04% | 0.0% |
| Q2 2021 | $38,210,000 | +9.7% | 126,913 | +0.3% | 0.04% | +2.6% |
| Q1 2021 | $34,836,000 | -3.5% | 126,496 | +3.1% | 0.04% | -2.5% |
| Q4 2020 | $36,081,000 | +8.9% | 122,686 | -2.8% | 0.04% | -2.4% |
| Q3 2020 | $33,132,000 | +15.8% | 126,209 | -0.6% | 0.04% | +13.9% |
| Q2 2020 | $28,606,000 | +76.2% | 127,009 | +3.1% | 0.04% | +50.0% |
| Q1 2020 | $16,231,000 | -14.3% | 123,217 | +4.5% | 0.02% | +9.1% |
| Q4 2019 | $18,929,000 | +82.1% | 117,923 | +29.3% | 0.02% | +69.2% |
| Q3 2019 | $10,396,000 | -11.3% | 91,224 | +10.2% | 0.01% | -13.3% |
| Q2 2019 | $11,723,000 | +19.1% | 82,804 | +5.0% | 0.02% | +15.4% |
| Q1 2019 | $9,845,000 | +35.2% | 78,864 | +4.0% | 0.01% | +18.2% |
| Q4 2018 | $7,284,000 | +66.3% | 75,820 | +31.3% | 0.01% | +120.0% |
| Q3 2018 | $4,379,000 | +449.4% | 57,741 | +500.2% | 0.01% | +400.0% |
| Q2 2018 | $797,000 | +53.3% | 9,620 | +48.7% | 0.00% | 0.0% |
| Q1 2018 | $520,000 | -9.2% | 6,470 | -28.7% | 0.00% | 0.0% |
| Q4 2017 | $573,000 | +1369.2% | 9,079 | +391.6% | 0.00% | – |
| Q2 2017 | $39,000 | – | 1,847 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |